EDGAR Filing Documents for 0001206774-10-001689

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001206774-10-001689

Filing Date

2010-07-28

Accepted

2010-07-28 07:30:36

Documents

Period of Report

2010-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	QUARTERLY REPORT	regeneron_10q.htm	10-Q	895832
2	SIXTH AMENDMENT TO LEASE, BY AND BETWEEN BMR-LANDMARK AT EASTVIEW LLC	exhibit10-1.htm	EX-10.1	68976
3	CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)	exhibit31-1.htm	EX-31.1	13389
4	CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)	exhibit31-2.htm	EX-31.2	11296
5	CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350	exhibit32.htm	EX-32	4399
	Complete submission text file	0001206774-10-001689.txt		3428720

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE DOCUMENT	regn-20100630.xml	EX-101.INS	442408
7	XBRL TAXONOMY EXTENSION SCHEMA	regn-20100630.xsd	EX-101.SCH	13838
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	regn-20100630_cal.xml	EX-101.CAL	38645
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	regn-20100630_lab.xml	EX-101.LAB	168628
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	regn-20100630_pre.xml	EX-101.PRE	101379
11	XBRL TAXONOMY EXTENSION DEFINITION DOCUMENT	regn-20100630_def.xml	EX-101.DEF	24666

Mailing Address

Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000

REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)